During the past decade, Dres. Michael Maasberg Marion Schmitz und Maria Theresia Keller conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dres. Michael Maasberg Marion Schmitz und Maria Theresia Keller" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Dres. Michael Maasberg Marion Schmitz und Maria Theresia Keller" are "Non-Hodgkin's Lymphoma" (1 trials), "Non-Small Cell Lung Cancer (NSCLC)" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Dres. Michael Maasberg Marion Schmitz und Maria Theresia Keller" in a lesser frequency.

Most popular intervention types in "Dres. Michael Maasberg Marion Schmitz und Maria Theresia Keller" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Chemotherapy (Induction Period)" (1 trials), "Cyclophosphamide" (1 trials), "Dose-dense Doxorubicin or dose-dense Epirubicin" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dres. Michael Maasberg Marion Schmitz und Maria Theresia Keller" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Dres. Michael Maasberg Marion Schmitz und Maria Theresia Keller". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Dres. Michael Maasberg Marion Schmitz und Maria Theresia Keller, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dres. Michael Maasberg Marion Schmitz und Maria Theresia Keller, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".